← Back to headlines
Eris Lifesciences and Natco Pharma Sign Pact on Semaglutide
Indian pharmaceutical companies Eris Lifesciences and Natco Pharma have entered into an agreement concerning the drug Semaglutide.
24 Feb, 16:36 — 24 Feb, 16:36
ℹOnly 1 source covers this story
